Steve Gelsi covers banking and cannabis as a Senior Reporter for MarketWatch.
Goldman Sachs Group Inc. GS, +0.19% has named two executives that lead its Office of Applied Innovation to head up its newly-launched Goldman Sachs Global Institute to provide clients with insights about geopolitics and technology, according to an internal memo seen by MarketWatch.
Jared Cohen and George Lee are leading the Goldman Sachs Global Institute after the firm saw a “strong appetite among clients for further engagement around the firm’s intellectual capital,” said Goldman Sachs Chief Executive David Solomon. Topics include U.S.-China diplomacy, Europe and Middle East conflicts, supply chain shifts and artificial intelligence. Goldman Sachs stock was up fractionally in recent trading.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Research Group Head, BeiGene Institute - Pudong New Area, Shanghai job with BeiGene InstituteAbout BeiGene and BeiGene Institute Over the past decade BeiGene has grown exponentially and become an industry leader with a robust drug pipeline combined with strong production capacity.
Weiterlesen »
Why Apple could be the big winner in its rocky partnership with Goldman SachsThe march toward a tech-driven financial sector seems inevitable
Weiterlesen »
With mortgage rates near 8%, Goldman Sachs sees home prices rebounding in 2024Goldman Sachs says mortgage rates will ‘remain elevated for the foreseeable future, dipping to just under 7% by the end of next year.’
Weiterlesen »
This under-the-radar consumer products stock could rally nearly 30%, Goldman Sachs saysThis consumer products manufacturer has a successful track record of market disruption and growth across categories, according to Goldman Sachs.
Weiterlesen »
Weight-loss drugs driving hedge fund consumer stock flows -Goldman SachsWeight-loss drugs driving hedge fund consumer stock flows -Goldman Sachs
Weiterlesen »
Weight-loss drugs driving hedge fund consumer stock flows -Goldman SachsHedge funds have been buying consumer staple stocks in Europe in October while dumping the sector in the U.S., driven by concerns about the impact of weight-loss drugs on food habits, Goldman Sachs showed in two different reports about trading flows.
Weiterlesen »